Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Assets (2016 - 2025)

Tg Therapeutics (TGTX) has 10 years of Return on Assets data on record, last reported at 0.33% in Q4 2025.

  • For Q4 2025, Return on Assets rose 33.0% year-over-year to 0.33%; the TTM value through Dec 2025 reached 0.33%, up 33.0%, while the annual FY2025 figure was 0.41%, 42.0% up from the prior year.
  • Return on Assets reached 0.33% in Q4 2025 per TGTX's latest filing, down from 0.49% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.49% in Q3 2025 and bottomed at 1.05% in Q2 2022.
  • Average Return on Assets over 5 years is 0.24%, with a median of 0.08% recorded in 2024.
  • Peak YoY movement for Return on Assets: soared 146bps in 2023, then plummeted -45bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.89% in 2021, then soared by 69bps to 0.28% in 2022, then soared by 115bps to 0.04% in 2023, then plummeted by -113bps to 0.01% in 2024, then skyrocketed by 6249bps to 0.33% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.33% in Q4 2025, 0.49% in Q3 2025, and 0.05% in Q2 2025.